Anti-Aging Startups

SFA Therapeutics develops oral therapeutic candidates based on deuterated short-chain fatty acids to treat autoimmune and oncologic diseases. The company's lead program, SFA-002, is in Phase 2 development for plaque psoriasis, with additional pipeline assets targeting pancreatic cancer, liver cancer, rheumatoid arthritis, and inflammatory bowel disease.

5 investors

Forever Labs operates a stem cell banking service that collects, processes, and cryopreserves adult stem cells from individuals for potential use in future regenerative therapies. The company connects patients with a network of board-certified physicians across the United States and coordinates cell storage and therapeutic activation.

4 investors

Rejuvenation develops proprietary mRNA and lipid nanoparticle technology to safely lengthen telomeres in human cells, targeting cellular aging and diseases caused by short telomeres including pulmonary fibrosis, liver disease, and bone marrow failure.

3 investors

dNovo develops direct reprogramming technology to convert skin, blood, or fat cells into new stem cells, targeting age-related stem cell depletion. The company aims to address aging through cellular regeneration for consumers.

2 investors

Dorian Therapeutics was a biotechnology startup developing senoblockers, drugs designed to rejuvenate cells and tissues by targeting aging-related mechanisms. Acquired by Altos Labs.

2 investors

Lygg develops a photostable chemical ingredient for skincare that provides enhanced protection against UVA radiation, tripling the effectiveness of existing FDA-approved options for sun damage prevention.

2 investors

Eat Blueprint prepares meals based on longevity-focused nutritional protocols, using organic and locally-sourced ingredients while excluding gluten and seed oils.

1 investor